• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Breaking Down the Positive and Negative Aspects of Direct-to-Consumer Advertising

by Karen Appold • December 12, 2022

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

American consumers are exposed to 4,000 to 10,000 advertisements every day (Simpson J. Finding brand success in the digital world. Forbes. August 25, 2017). Ads come in all shapes and sizes, including print, TV, and radio ads, logos, billboards, and social media sponsored posts. According to the Consumer Healthcare Products Association, upper respiratory medications are by far the highest-selling segment of the over-the-counter (OTC) drug market, with 1.15 billion units sold in 2017.

You Might Also Like

  • COSM 2012: TRIO Guest of Honor Cautions against Physician Advertising
  • Report: Physician Prescribing Behavior Changes Following Restrictions on Direct Marketing
  • EMR and Advertising: Strange Bedfellows?
  • Juul Suspends U.S. Advertising, CEO Steps Down
Explore This Issue
December 2022

The connection between these two figures isn’t accidental. Spending for prescription drugs for respiratory conditions is also off the charts. In September 2022 alone, Regeneron/Sanofi, Tarrytown, N.Y., spent the most ever ($29.4 million) on TV advertising for one drug—Dupixent (dupilumab)—in the United States (Adams B. AbbVie continues top TV drug ad spender reign and Pfizer’s Comirnaty makes new appearance, as overall spend jumps. Fierce Pharma. October 10, 2022). “Dupixent is FDA approved for multiple uses, but this spend is still quite high,” said Janelle Applequist, PhD, MA, an associate professor at the Zimmerman School of Advertising & Mass Communications at the University of South Florida in Tampa.

“Ads are all around us because they drive sales,” Dr. Applequist said. “When someone is in the market for a particular product, they’re more inclined to pay attention to an ad.”

Ads can be informational, where they attempt to help people avoid or solve problems, or transformational, where they offer something additional through sensory gratification, social approval, or the promise of a better life, Dr. Applequist said. Directto- consumer advertising (DTCA) is good at doing both—providing information about a product, but also using imagery that signifies a happier life just within reach.

Televised prescription drug ads often feature smiling patients stepping out into a brightly lit world surrounded by loved ones. This type of marketing often discusses potential harms as an afterthought in rushed voiceovers. —Vinay Rathi, MD, MBA

By pushing viewers to talk to their doctors about a certain drug, such as Dupixent, a branded drug has the already-worried, captive viewer in a false state of empowerment. “Consumers may not know that only the most expensive, newest drugs are currently advertised,” Dr. Applequist noted. “Patients may think that products will provide a quick fix for their ailments, but ads are designed to divert their attention in order to highlight a product’s benefits while still remaining legally compliant with FDA mandates, which require an equal presentation of drug benefits and risks to be present in DTCA.” What seems like a helpful act of suggesting a drug to their physician may not present an entirely accurate picture.

Pages: 1 2 3 4 5 6 7 | Single Page

Filed Under: Features, Home Slider Tagged With: advertising, patient careIssue: December 2022

You Might Also Like:

  • COSM 2012: TRIO Guest of Honor Cautions against Physician Advertising
  • Report: Physician Prescribing Behavior Changes Following Restrictions on Direct Marketing
  • EMR and Advertising: Strange Bedfellows?
  • Juul Suspends U.S. Advertising, CEO Steps Down

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • A Journey Through Pay Inequity: A Physician’s Firsthand Account

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939